Ronald Klain was White House Ebola Response Coordinator from 2014 to 2015. This post has been updated and adopted from the author’s piece, Confronting the Pandemic Threat, published in Democracy Journal (No. 40, Spring 2016).
This week marks one year since the first known COVID-19 death. And while the remarkable pace of vaccine development is widely praised, the lag in its distribution is concerning.
What would happen if genetic sequencing were standard care for undiagnosed diseases? And how can we ensure that the future of genomics benefits everyone, not just the one percent?
Thank you for signing up!
Please provide a valid email address.